Clinical Trials Directory

Trials / Completed

CompletedNCT02097316

Feasibility Study of the JewelPump Version 3

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study will be conducted, in cross-over with a time interval of at least 2 days between 2 treatment periods. Patients will be randomized into 2 groups According to the order of the randomization, patients will bear the JewelPump for 5 days, followed by a period of 5 days of treatment with their usual pumps.

Detailed description

The JewelPump (Debiotech) will be compared to the conventional pumps. Patients will treated with the JewelPump during 5 days, and with their usual pump during 5 other days. The study will be conduct with 15 patients at the following investigation centers : Corbeil Hospital, CHU of Strasbourg, and CHRU of Marseille.

Conditions

Interventions

TypeNameDescription
DEVICEJewelPump
DEVICEusual insulin pump

Timeline

Start date
2014-06-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2014-03-27
Last updated
2014-10-27

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02097316. Inclusion in this directory is not an endorsement.